BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 18833193)

  • 1. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies.
    Bosnakovski D; Xu Z; Gang EJ; Galindo CL; Liu M; Simsek T; Garner HR; Agha-Mohammadi S; Tassin A; Coppée F; Belayew A; Perlingeiro RR; Kyba M
    EMBO J; 2008 Oct; 27(20):2766-79. PubMed ID: 18833193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures.
    Haynes P; Kernan K; Zhou SL; Miller DG
    Skelet Muscle; 2017 Jun; 7(1):13. PubMed ID: 28637492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DUX4 homeodomains mediate inhibition of myogenesis and are functionally exchangeable with the Pax7 homeodomain.
    Bosnakovski D; Toso EA; Hartweck LM; Magli A; Lee HA; Thompson ER; Dandapat A; Perlingeiro RCR; Kyba M
    J Cell Sci; 2017 Nov; 130(21):3685-3697. PubMed ID: 28935672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAX7 target gene repression is a superior FSHD biomarker than DUX4 target gene activation, associating with pathological severity and identifying FSHD at the single-cell level.
    Banerji CRS; Zammit PS
    Hum Mol Genet; 2019 Jul; 28(13):2224-2236. PubMed ID: 31067297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle.
    Banerji CRS; Panamarova M; Hebaishi H; White RB; Relaix F; Severini S; Zammit PS
    Nat Commun; 2017 Dec; 8(1):2152. PubMed ID: 29255294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients.
    Dmitriev P; Bou Saada Y; Dib C; Ansseau E; Barat A; Hamade A; Dessen P; Robert T; Lazar V; Louzada RAN; Dupuy C; Zakharova V; Carnac G; Lipinski M; Vassetzky YS
    Free Radic Biol Med; 2016 Oct; 99():244-258. PubMed ID: 27519269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?
    Tassin A; Laoudj-Chenivesse D; Vanderplanck C; Barro M; Charron S; Ansseau E; Chen YW; Mercier J; Coppée F; Belayew A
    J Cell Mol Med; 2013 Jan; 17(1):76-89. PubMed ID: 23206257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct interplay between two candidate genes in FSHD muscular dystrophy.
    Ferri G; Huichalaf CH; Caccia R; Gabellini D
    Hum Mol Genet; 2015 Mar; 24(5):1256-66. PubMed ID: 25326393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7.
    Banerji CRS; Zammit PS
    EMBO Mol Med; 2021 Aug; 13(8):e13695. PubMed ID: 34151531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei.
    Vanderplanck C; Tassin A; Ansseau E; Charron S; Wauters A; Lancelot C; Vancutsem K; Laoudj-Chenivesse D; Belayew A; Coppée F
    Skelet Muscle; 2018 Jan; 8(1):2. PubMed ID: 29329560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FSHD atrophic myotube phenotype is caused by DUX4 expression.
    Vanderplanck C; Ansseau E; Charron S; Stricwant N; Tassin A; Laoudj-Chenivesse D; Wilton SD; Coppée F; Belayew A
    PLoS One; 2011; 6(10):e26820. PubMed ID: 22053214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic myopathic phenotype of mouse DUX, an ORF within conserved FSHD-related repeats.
    Bosnakovski D; Daughters RS; Xu Z; Slack JM; Kyba M
    PLoS One; 2009 Sep; 4(9):e7003. PubMed ID: 19756142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage.
    Bou Saada Y; Dib C; Dmitriev P; Hamade A; Carnac G; Laoudj-Chenivesse D; Lipinski M; Vassetzky YS
    Histochem Cell Biol; 2016 Apr; 145(4):475-83. PubMed ID: 26860865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy.
    Oliva J; Galasinski S; Richey A; Campbell AE; Meyers MJ; Modi N; Zhong JW; Tawil R; Tapscott SJ; Sverdrup FM
    J Pharmacol Exp Ther; 2019 Aug; 370(2):219-230. PubMed ID: 31189728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression during normal and FSHD myogenesis.
    Tsumagari K; Chang SC; Lacey M; Baribault C; Chittur SV; Sowden J; Tawil R; Crawford GE; Ehrlich M
    BMC Med Genomics; 2011 Sep; 4():67. PubMed ID: 21951698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity.
    Jones TI; Chew GL; Barraza-Flores P; Schreier S; Ramirez M; Wuebbles RD; Burkin DJ; Bradley RK; Jones PL
    Skelet Muscle; 2020 Apr; 10(1):8. PubMed ID: 32278354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy.
    Bittel AJ; Sreetama SC; Bittel DC; Horn A; Novak JS; Yokota T; Zhang A; Maruyama R; Rowel Q Lim K; Jaiswal JK; Chen YW
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity.
    Teveroni E; Pellegrino M; Sacconi S; Calandra P; Cascino I; Farioli-Vecchioli S; Puma A; Garibaldi M; Morosetti R; Tasca G; Ricci E; Trevisan CP; Galluzzi G; Pontecorvi A; Crescenzi M; Deidda G; Moretti F
    J Clin Invest; 2017 Apr; 127(4):1531-1545. PubMed ID: 28263188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy.
    Banerji CR; Knopp P; Moyle LA; Severini S; Orrell RW; Teschendorff AE; Zammit PS
    J R Soc Interface; 2015 Jan; 12(102):20140797. PubMed ID: 25551153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis.
    Young JM; Whiddon JL; Yao Z; Kasinathan B; Snider L; Geng LN; Balog J; Tawil R; van der Maarel SM; Tapscott SJ
    PLoS Genet; 2013 Nov; 9(11):e1003947. PubMed ID: 24278031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.